Page last updated: 2024-08-23

1,2-diacetylbenzene and risperidone

1,2-diacetylbenzene has been researched along with risperidone in 2 studies

*Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA. [MeSH]

*Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA. [MeSH]

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Hoang, NHM; Jo, WH; Kim, MS; Nguyen, HD1
Duc Nguyen, H; Hee Jo, W; Hong Minh Hoang, N; Kim, MS1

Other Studies

2 other study(ies) available for 1,2-diacetylbenzene and risperidone

ArticleYear
Risperidone ameliorated 1,2-Diacetylbenzene-induced cognitive impairments in mice via activating prolactin signaling pathways.
    International immunopharmacology, 2023, Volume: 115

    Topics: Animals; Cognitive Dysfunction; Glycogen Synthase Kinase 3 beta; Mice; MicroRNAs; Prolactin; Risperidone; Signal Transduction

2023
Short-term treatment with risperidone ameliorated 1,2-diacetylbenzene-induced liver dysfunction.
    International immunopharmacology, 2023, Volume: 123

    Topics: Animals; Caspase 3; Liver; Liver Diseases; Male; Mice; Mice, Inbred C57BL; MicroRNAs; NF-kappa B; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Risperidone; Tumor Necrosis Factor-alpha

2023